Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.3822
+0.0031 (0.82%)
At close: Feb 11, 2026

Avaí Bio Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
5366111553179
Market Cap Growth
-45.03%-40.41%102.08%76.33%-60.75%-
Enterprise Value
5467111553280
Last Close Price
0.380.480.991.501.183.01
PS Ratio
---198.1633.7165.16
PB Ratio
-22.93-42.16-75.45-86.47-76.57-241.61
EV/Sales Ratio
---199.9434.4365.50
Debt / Equity Ratio
-0.57-0.58-0.48-1.01-1.48-1.29
Net Debt / Equity Ratio
-0.53-0.53-0.48-0.84-1.40-1.11
Net Debt / EBITDA Ratio
-1.39-0.77-0.34-1.63-6.30-1.46
Net Debt / FCF Ratio
-1.32-0.71-0.53-9.74-1.06-15.74
Asset Turnover
---0.791.451.96
Quick Ratio
0.040.0500.120.040.11
Current Ratio
0.050.050.070.120.390.54
Return on Assets (ROA)
-282.13%-261.11%-472.18%-62.66%-12.44%-30.57%
Return on Capital Employed (ROCE)
40.50%73.00%145.10%55.10%31.20%92.30%
Earnings Yield
-1.76%-1.73%-1.92%-0.64%-0.41%-0.38%
FCF Yield
--1.76%-1.20%-0.10%-1.72%-0.03%
Buyback Yield / Dilution
-24.77%-48.09%-124.74%-46.31%-0.13%-29.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.